Literature DB >> 25769799

Carboxyhemoglobin and methemoglobin levels as prognostic markers in acute pulmonary embolism.

Sotirios Kakavas1, Aggeliki Papanikolaou2, Evangelos Ballis3, Nikolaos Tatsis4, Christina Goga5, Georgios Tatsis6.   

Abstract

OBJECTIVES: Carboxyhemoglobin (COHb) and methemoglobin (MetHb) levels have been associated with a poor outcome in patients with various pathological conditions including cardiovascular diseases. Our aim was to retrospectively assess the prognostic value of arterial COHb and MetHb in patients with acute pulmonary embolism (PE).
METHODS: We conducted a retrospective study of 156 patients admitted in a pulmonary clinic due to acute PE. Measured variables during emergency department evaluation that were retrospectively analyzed included the ratio of the partial pressure of oxygen in arterial blood to the fraction of oxygen in inspired gas, Acute Physiology and Chronic Health Evaluation II score, risk stratification indices, and arterial blood gases. The association between arterial COHb and MetHb levels and disease severity or mortality was evaluated using bivariate tests and logistic regression analysis.
RESULTS: Arterial COHb and MetHb levels correlated with Acute Physiology and Chronic Health Evaluation II and pulmonary severity index scores. Furthermore, arterial COHb and MetHb levels were associated with troponin T and N-terminal pro-B-type natriuretic peptide levels. In univariate logistic regression analysis, COHb and MetHb levels were both significantly associated with an increased risk of death. However, in multivariate analysis, only COHb remained significant as an independent predictor of in-hospital mortality.
CONCLUSION: Our preliminary data suggest that arterial COHb and MetHb levels reflect the severity of acute PE, whereas COHb levels are independent predictors of in hospital death in patients in this clinical setting. These findings require further prospective validation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769799     DOI: 10.1016/j.ajem.2015.01.046

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Authors:  Jeffrey A Kline; Nury M Steuerwald; John A Watts; Mark Courtney; Herbert L Bonkovsky
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

2.  Mortality Related Risk Factors in High-Risk Pulmonary Embolism in the ICU.

Authors:  Begüm Ergan; Recai Ergün; Taner Çalışkan; Kutlay Aydın; Murat Emre Tokur; Yusuf Savran; Uğur Koca; Bilgin Cömert; Necati Gökmen
Journal:  Can Respir J       Date:  2016-11-29       Impact factor: 2.409

3.  The Importance and Place of Methemoglobin and Carboxyhemoglobin Levels in the Diagnosis and Prognosis of Pulmonary Embolism.

Authors:  Fatih Uzer; Omer Ozbudak
Journal:  Tanaffos       Date:  2019-01

4.  Endogenous Carboxyhemoglobin Level Variation in COVID-19 and Bacterial Sepsis: A Novel Approach?

Authors:  Bianca-Liana Grigorescu; Irina Săplăcan; Ioana Roxana Bordea; Marius Petrisor; Oana Coman; Claudiu Ion Puiac; Ariana Toncean; Raluca Stefania Fodor
Journal:  Microorganisms       Date:  2022-01-27

5.  Carboxyhemoglobin Does Not Predict the Need of Mechanical Ventilation and Prognosis during COPD Exacerbation.

Authors:  Shimon Izhakian; Eitan Harper; Oleg Gorelik; Assaf Frajman; Ori Mekiten; Adina Bar-Chaim; Mordechai Reuven Kramer
Journal:  Can Respir J       Date:  2022-04-16       Impact factor: 2.130

6.  Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients?

Authors:  Buğra Kerget; Ferhan Kerget; Abdullah Osman Koçak; İlker Akbaş; Ömer Araz; Elif Yılmazel Uçar; Metin Akgün
Journal:  Int J Clin Pract       Date:  2021-08-06       Impact factor: 3.149

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.